Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Enhanced risk stratification in AML through integrated mutation and CNV profiling: Insights from Uruguay

Matilde Boada, Ana Ines Catalan, Carolina Ottati, Sabrina ranero Ferrari, Cristina Otero, Ana Ines Landoni, Gabriela de Galvez, Mariana Lorenzo, Francis Kescherman, Gimena dos Santos, Lilian Diaz, Regina Guadagna, Alberto Vazquez, Maria Spangenberg, Laura Topolansky, Natalia Tejeira, Daniela Lens, Sofia Grille

Blood (2025) 146 (Supplement 1): 7001.

https://doi.org/10.1182/blood-2025-7001

Published: 2025

Journal Articles

Measurable residual disease (MRD) assessment as an early end point oftreatment efficacy in acute myeloid leukemia (AML): A pethema studyof 2,623 patients (Pts) treated with intensive therapy

Bruno Paiva, Leire Burgos, Carmen Gonzalez, Rebeca Rodriguez Veiga, Antonio Solana-Altabella, Pilar Lloret-Madrid, Evelyn Acuña-Cruz, Cristina Gil, Carmen Botella, Eduardo Rodríguez-Arbolí, Teresa Caballero, Teresa Bernal Del Castillo, Maria Teresa Cedena Romero, Pilar Herrera Puente, Claudia Sossa, Josefina Serrano, Joaquín Sánchez-García, José Luis López Lorenzo, María-Belén Vidriales, Mar Tormo, Monica Romero, Mercedes Colorado, Celina Benavente, Juan Miguel Bergua Burgues, Manuel Pérez-Encinas, Lorenzo Algarra, Carlos Rodríguez-Medina, Dolly Viviana Fiallo Suarez, Raimundo García-Boyero, Luis Felipe Casado Montero, Jorge Labrador, Manuel Barrios García, Beatriz De Rueda Ciller, Marcela Espinoza, Maria Jose Sayas Lloris, Diana Cuervo, María Luz Amigo, Jose-Mario Mariz, Karoll Giovanna Gomez Correcha, Carmen Couto, Esther Perez, Ágata Almela, Susana Vives, Esperanza Lavilla-Rubira, Olga Arce-Fernández, Maria Teresa Olave Rubio, Miguel Lopez, Maria Dolores Madrigal, Lara María Gómez García, Sofia Grille, Sebastián Hidalgo, Daniel García Belmonte, Maria Jose Garcia, Maria Del Carmen Martinez Chamorro, Olga Salamero, Amparo Sempere, Beatriz Martín Herreros, Armando Mena Duran, David Martinez-Cuadron, Pau Montesinos

Blood (2025) 146 (Supplement 1): 5293.

https://doi.org/10.1182/blood-2025-5293

Published: 2025

Journal Articles

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Blood (2024) 144 (Supplement 1): 6718.

https://doi.org/10.1182/blood-2024-209513

Published: 2024

Journal Articles

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Blood (2023) 142 (Supplement 1): 5179.

https://doi.org/10.1182/blood-2023-185122

Published: 2023

Journal Articles

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Marcelo Iastrebner, Renee Leonor Crisp, Roberto Ovilla, Andres Gomez-De Leon, Adriana Karola Puente, Fernando Barroso Duarte, Elvira DRP Velloso, Breno Gusmao, Ana Varela, Matilde Boada, Sofia Grille

Blood (2022) 140 (Supplement 1): 12329–12330.

https://doi.org/10.1182/blood-2022-163174

Published: 2022

Journal Articles

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Sofia Grille, Elvira DRP Velloso, Matilde Boada, Elia Apodaca Chavez, Andres Gomez-De Leon, Anna Cecilia Rodríguez-Zuñiga, Emmanuel Martínez Moreno, Fernando Perez-Jacobo, Graciela Alfonso, Juan Carlos Serrano, Natalia Tejeira, Lilián Díaz, Valentina Olivares, Laura Kornblihtt, Sergio Schusterschitz, Marcelo Iastrebner

Blood (2022) 140 (Supplement 1): 4096–4097.

https://doi.org/10.1182/blood-2022-168893

Published: 2022

Journal Articles

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

Bruno Paiva, PhD, María Belén Vidriales, Maria Desamparados Sampere Talens, Fabian Tarin, Enrique Colado, Celina Benavente, María Teresa Cedena, MD, Joaquin Sanchez, MD, Teresa Caballero-Velázquez, MD PhD, Lourdes Cordon, David Martínez-Cuadron, MD, Teresa Bernal del Castillo, MD PhD, Carmen Botella, Sofia Grille, MDPhD, Josefina Serrano, MD, Carlos Rodriguez, Jesús Lorenzo Algarra, Juan Manuel Alonso Dominguez, MD PhD MSc, Maria Luz Amigo, MD, Manuel BARRIOS García, MDPhD, Raimundo García-Boyero, MD, Mercedes Colorado, MD, Jaime Perez De Oteyza, MDPhD, Manuel Perez Encinas, MD, Lissette Del Pilar Costilla, MD, Maria Jose Sayas, Olga Pérez-López, Marcos González, Jose A. Perez-Simon, MD PhD, Joaquin Martinez-Lopez, MD PhD, Claudia Lucia Sossa, Alberto Orfao, MD PhD, Jesús F. San-Miguel, Miguel Sanz, MD PhD, Pau Montesinos, MD PhD

Blood (2020) 136 (Supplement 1): 13–15.

https://doi.org/10.1182/blood-2020-134349

Published: 2020

Journal Articles

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Roberto Ovilla, MD, Renee Leonor Crisp, PhD, Pamela E Baez-Islas, MD, Jorge A Arbelbide, MD, Sofia Grille, MD PhD, Lilián Díaz, MD, Henry Idrobo, MD Professor, Alicia Enrico, MD, Maria J Mela Osorio, MD, Isolda I. Fernandez, MD, Luciana C Ferrari, MD, Nidia Zapata, MD, Adrian A Ceballos-Lopez, Veronica Mena, MD, Ana L Romero, MD, Juan Carlos Serrano, MD, Gabriela Vidal-Senmache, MD, Fernando Barroso Duarte, MD, Edit N Pintos, MD, Mariana Rosenhain, MD, Laura Kornblihtt, MD, Natalia Tejeira, MD, Breno Gusmao, MD, Maria Elena Del Rocio Buenaño, MD, Marcos Di Stefano, MD, Matilde Boada, MD, Alberto Gimenez Conca, MD, Maria Perusini, MD, Hernan Dick, MD, Santiago Cranco, MD, Maria Lucia Fuente, Alicia Beatriz Navickas, MD, Maria M Moirano, MD, Natalia Oliveira, MD, Jacqueline Gonzalez, MD, Mariana Bandín, MD, Noelia Villaverde, MD, Alejandro Suero, MD, Juan Felipe Lasso, MD, Nora Carrara, MD, Xochitl Cota, MD, Carolina Lazzarino, MD, Maria Leticia Rapan, MD, Marcelo Iastrebner, MD, Latin-American MDS Group (GLAM), MDS and Acute Leukemia Sub-Commission Group Argentinian Society of Hematology

Blood (2019) 134 (Supplement_1): 5096.

https://doi.org/10.1182/blood-2019-125311

Published: 2019

Journal Articles

Febrile Neutropenia Outcome in Hemato-Oncological Patients after the Implementation of an Adapted Therapeutic Protocol at a University Hospital in Uruguay

Sofia Grille, MD PhD, Boada Matilde, MD, Regina Guadagna, MD, Maria Noel Spangenber, MD, Felipe Lemos, MD, Mariana Stevenazzi, MD, Lilian Diaz, MD, Cecilia Guillermo, MD

Blood (2015) 126 (23): 4471.

https://doi.org/10.1182/blood.V126.23.4471.4471

Published: 2015

Journal Articles

Salmonella Enterica serovar Typhimurium As a Therapy for B-Cell Lymphoma

Sofia Grille, MD, PhD, María Moreno, PhD, Jose Alejandro Chabalgoity, PhD, Daniela Lens, MD, PhD

Blood (2011) 118 (21): 4968.

https://doi.org/10.1182/blood.V118.21.4968.4968

Published: 2011

Journal Articles

A Therapeutic Vaccine Using Activated Tumor Cells by Salmonella Infection and Interleukin-2 Induces Antitumor Immunity In B-Cell Lymphoma

Sofia Grille, MD, PhD, María Moreno, PhD, Andreina Brugnini, José A. Chabalgoity, PhD, Daniela Lens, MD, PhD

Blood (2010) 116 (21): 2841.

https://doi.org/10.1182/blood.V116.21.2841.2841

Published: 2010

Journal Articles

Depot Formulation of Interleukin-2 as an Immunotheraphy for B-Cell Lymphoma.

Sofia Grille, MD, Andreina Brugnini Lic, Esteban Corley, PhD, Martha Nese, MD, Jose Alejandro Chabalgoity, PhD, Daniela Lens, PhD

Blood (2007) 110 (11): 1398.

https://doi.org/10.1182/blood.V110.11.1398.1398

Published: 2007

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Enhanced risk stratification in AML through integrated mutation and CNV profiling: Insights from Uruguay

Measurable residual disease (MRD) assessment as an early end point oftreatment efficacy in acute myeloid leukemia (AML): A pethema studyof 2,623 patients (Pts) treated with intensive therapy

Azacitidine and Venetoclax in High-Risk Myelodysplastic Syndrome: A Real-World Perspective from the Glam Registry with Long-Term Follow-up

Comparison of the Revised 4 Th (2016) and 5 Th (2022) Editions of the World Health Organization (WHO) Classification in a Cohort of Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms (MDS) - a Glam Registry (REGLAM) Analysis

Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam

Myelodysplastic Syndromes in Latin-America - Results from a Novel International Registry: Re-Glam

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

Secondary Acute Myeloid Leukemia: Demographic, Physiopathogenic, Clinical and Therapeutic Comparative Study

Febrile Neutropenia Outcome in Hemato-Oncological Patients after the Implementation of an Adapted Therapeutic Protocol at a University Hospital in Uruguay

Salmonella Enterica serovar Typhimurium As a Therapy for B-Cell Lymphoma

A Therapeutic Vaccine Using Activated Tumor Cells by Salmonella Infection and Interleukin-2 Induces Antitumor Immunity In B-Cell Lymphoma

Depot Formulation of Interleukin-2 as an Immunotheraphy for B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only